Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 12;10(14):3935-3950.
doi: 10.1039/d1bm01933c.

Inter-donor variability of extracellular matrix production in long-term cultures of human fibroblasts

Affiliations

Inter-donor variability of extracellular matrix production in long-term cultures of human fibroblasts

Fabien Kawecki et al. Biomater Sci. .

Abstract

Several tissue engineering approaches are based on the ability of mesenchymal cells to endogenously synthesize an extracellular matrix (ECM) in vitro, which can be seen as a form of biomaterial. Accordingly, the inter-donor variability of cell-assembled extracellular matrix (CAM) production is a key parameter to understand in order to progress towards clinical applications, especially for autologous strategies. In this study, CAMs were produced, under good manufacturing process conditions, from skin fibroblasts of 21 patients as part of a clinical trial to evaluate a tissue-engineered vascular graft. The inter-donor variability of CAM strength, thickness, hydroxyproline, and glycosaminoglycan was substantial (coefficient of variability of 33%, 19%, 24%, and 19%, respectively), but a significant correlation was observed between all four properties (Pearson r: 0.43 to 0.70; p-value ≤ 0.05). A CAM matrisome analysis, performed by mass spectrometry, revealed the presence of 70 ECM-related proteins. Our study shows that the relative abundance of 16 proteins (15 non-collagenous) correlated with CAM thickness. These proteins also correlated with CAM hydroxyproline content, as well as 21 other proteins that included fibrillar collagens and non-collagenous proteins. However, data demonstrated that only the relative abundance of type I collagen subunit alpha-1 was correlated to CAM strength. This study is the most extensive evaluation of CAM inter-donor variability to date and will help tissue engineers working with this type of biomaterial to design strategies that take into account this variability, especially for autologous tissue manufacturing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.

Figures

Fig. 1
Fig. 1. Strength, thickness, hydroxyproline, and sulfated glycosaminoglycan inter-donor variabilities. The CAMs produced by fibroblastic cell populations from 21 donors were evaluated. (A) CAM perforation strength had a mean of 530 gf (black line) and a standard deviation of ±173 gf (dotted lines) and showed the highest level of variability with a coefficient of variation of 33%. (B) CAM thickness had a mean of 91 μm (black line) and a standard deviation of ±17 μm (dotted lines) and was the more constant CAM property. (C) CAM hydroxyproline content showed a mean of 0.73 μg mm−2 (black line) and a standard deviation of ±0.17 μg mm−2 (dotted lines). (D) CAM sGAGs displayed a mean of 0.37 μg mm−2 (black line) and a standard deviation of ±0.07 μg mm−2 (dotted lines) with 19% of variability between donors. The results of each donor show the mean ± SD. Tukey box plots present the median (central black line), the interquartile range (box), the upper and lower values (“whiskers”), and the outliers (dots).
Fig. 2
Fig. 2. Relationships between CAM properties. (A) CAM strength displayed a moderate positive correlation with CAM thickness and (B) strongly correlated with hydroxyproline content. (C) A moderate positive correlation existed between CAM thickness and hydroxyproline content, indicating that the two properties are interrelated. (D–F) The sulfated glycosaminoglycan quantity constituting the CAM showed strong correlation with the strength property and moderate relationships with CAM thickness and hydroxyproline content.
Fig. 3
Fig. 3. Variability of the proteomic composition of CAMs produced by human dermal fibroblasts obtained from 21 donors. Heat map of the protein abundance fold-difference from the mean of all donors using a Log2 color scale (−7.2 to 7.2). For each protein group, the Log2 of the mean fold-change was plotted (black lines, axis on the right). Mean fold-changes for all proteins are indicated for each donor at the bottom using a separate Log2 color scale. Data were collected from three technical replicates, and only matrisome proteins identified with at least two unique peptides were considered. Black crosses indicate proteins that were not detected.
Fig. 4
Fig. 4. Collagen alpha-1(I) chain (COL1A1) correlation with CAM properties. (A) An elevated COL1A1 variation was measured with a global protein abundance mean of 1.1 × 1010 (black line) and a standard deviation of ± 8.4 × 109 (dotted lines). Tukey box plot of COL1A1 abundance was realized to describe the distribution between donors. (B) COL1A1 displays a moderate positive correlation with CAM strength.
Fig. 5
Fig. 5. Network of correlation between COL1A1 and the detected matrisome proteins. Each colored node represents a protein (collagen proteins: bleu, glycoproteins: purple, proteoglycans: gray, ECM-affiliated proteins: orange, and ECM regulators: green) or a CAM property (strength: dark green, thickness: pink, and hydroxyproline: beige). The width of the links denotes the Pearson coefficient intensity (0.43 to 0.99; written in red) that is statistically significant (p < 0.05).

References

    1. Langer R. Vacanti J. Science. 1993;260:920–926. doi: 10.1126/science.8493529. - DOI - PubMed
    1. Langer R. Vacanti J. J. Pediatr. Surg. 2016;51:8–12. doi: 10.1016/j.jpedsurg.2015.10.022. - DOI - PMC - PubMed
    1. Luo Y. Engelmayr G. Auguste D. T. Ferreira L. da S. Karp J. M. Saigal R. Princ. Tissue Eng. 2007:359–373.
    1. Yi S. Ding F. Gong L. Gu X. Curr. Stem Cell Res. Ther. 2017;12:233–246. doi: 10.2174/1574888X11666160905092513. - DOI - PubMed
    1. Chan B. P. and Leong K. W., European Spine Journal, 2008, vol. 17, pp. 467–479 - PMC - PubMed

LinkOut - more resources